Long-term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104-week VERTIS MET trial (Q90917067)
Jump to navigation
Jump to search
scientific article published on 14 February 2019
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104-week VERTIS MET trial |
scientific article published on 14 February 2019 |
Statements
Long-term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104-week VERTIS MET trial (English)
Silvina Gallo
Bernard Charbonnel
Harry Shi
Susan Huyck